EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Medicine–Food Homology Plants and Bioactive Compounds in Polyendocrine Metabolic Ovarian Syndrome: Multi-Target Mechanisms and Functional Food Potential—A Review

Qiuni Yang, Linzuo Zou, Yuxue Huang, Qingfeng Zhang, Chengyao He, Li Cheng, Chao Zhao

Nutrients · 2026

DOI: 10.3390/nu18172837 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Qiuni Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang 550002, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Plants, Edible, Functional Food, Phytochemicals. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Administration of Traditional Chinese Medicine of the People's Republic of China, Guizhou Provincial Science and Technology Department, Guiyang College of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyendocrine metabolic ovarian syndrome (PMOS), renamed from polycystic ovary syndrome (PCOS) by global consensus in May 2026, is one of the most common endocrine diseases in women of reproductive age, affecting physical and mental health. Growing evidence suggests that medicine–food homology (MFH) plants and their bioactive compounds may help regulate PMOS-related metabolism and reproductive abnormalities through dietary intervention. This review summarizes their reported roles and potential mechanisms. Based on the existing literature, this review presents nine edible plant resources identified under the MFH/dietary-use framework and 21 bioactive constituents or constituent classes, all selected for detailed synthesis from a broader eligible evidence base and with reported PMOS-related bioactivity. Across preclinical studies, these constituents appear to act through convergent, multi-target mechanisms, including anti-inflammatory and antioxidant activities to reduce systemic inflammation, as well as restoring hormone balance, correcting abnormal lipid metabolism, relieving insulin resistance and protecting ovarian function. Importantly, the evidence base remains predominantly preclinical, with few human randomized trials. Key translational barriers include insufficient standardization of preparations and doses, limited oral bioavailability of several constituents, safety and herb–drug interaction concerns, and uncertain formulation feasibility for functional-food applications. By integrating evidence at the plant and compound levels, this review provides a mechanistic rationale—rather than clinical proof—for further investigation of dietary strategies relevant to PMOS and proposes a framework for the development and evaluation of MFH-based functional foods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromePlants, EdibleFunctional FoodPhytochemicalsPlants, MedicinalMetabolic SyndromeHumansFemaleAnimalsInsulin Resistance

Stichwörter der Autor:innen

dietary interventionhyperandrogenisminflammationinsulin resistanceoxidative stresspolycystic ovary syndromesteroidogenesis

Substanzen

Phytochemicals

Autor:innen und Institutionen

  • The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang 550002, China.
  • Yuni Township Health Centre, Panzhou 553523, China.
  • The Research Center for Quality Control of Natural Medicine, Guizhou Normal University, Guiyang 550001, China.

Förderung

  • State Administration of Traditional Chinese Medicine of the People's Republic of China
  • Guizhou Provincial Science and Technology Department
  • Guiyang College of Traditional Chinese Medicine
  • State Administration of Traditional Chinese Medicine of the People’s Republic of China
  • Guizhou Provincial Science and Technology Innovation Leading Talent
  • Guizhou University of Traditional Chinese Medicine

Zitieren

APA

Yang, Q., Zou, L., Huang, Y., Zhang, Q., He, C., Cheng, L., & Zhao, C. (2026). Medicine–Food Homology Plants and Bioactive Compounds in Polyendocrine Metabolic Ovarian Syndrome: Multi-Target Mechanisms and Functional Food Potential—A Review. Nutrients. https://doi.org/10.3390/nu18172837

Vancouver

Yang Q, Zou L, Huang Y, Zhang Q, He C, Cheng L, et al. Medicine–Food Homology Plants and Bioactive Compounds in Polyendocrine Metabolic Ovarian Syndrome: Multi-Target Mechanisms and Functional Food Potential—A Review. Nutrients. 2026. doi:10.3390/nu18172837

BibTeX
@article{Yang2026,
  author = {Yang, Qiuni and Zou, Linzuo and Huang, Yuxue and Zhang, Qingfeng and He, Chengyao and Cheng, Li and Zhao, Chao},
  title = {Medicine–Food Homology Plants and Bioactive Compounds in Polyendocrine Metabolic Ovarian Syndrome: Multi-Target Mechanisms and Functional Food Potential—A Review},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18172837}
}
Kostenlos starten →